Neoplasia/BPH

	Identifying a critical skeletal muscle threshold and systemic predictors for acute urinary retention in benign prostatic hyperplasia with sarcopenia: an internally validated model. Front Endocrinol (Lausanne) Yang Q, Xu Y, Hou S, Yang B, Huang L. PMID: 42845696 [PubMed - indexed for MEDLINE]
	Improved survival in newly diagnosed metastatic prostate cancer: a National Prostate Cancer Audit study. BJU Int Nathan A, Parry MG, Mayne E, Cook A, Liu J, Varma R, Cuningham W, Dodkins J, Parry M, Nossiter J, Aggarwal A, van der Meulen J, Tree A, Clarke N. PMID: 42845147 [PubMed - as supplied by publisher]
	MITF-Overexpressing Perivascular Epithelioid Cell Tumor of the Urinary Bladder Lacking TSC1/TSC2 Alterations and TFE3 Rearrangement: A Case Report and Review of the Literature. Pathol Int Jeong JI, Lee J, Oh MH, Cho HD, Lee JH, Jeon YS, Jang SH. PMID: 42844916 [PubMed - indexed for MEDLINE]
	Longitudinally Monitoring Prostate Cancer Bone Metastasis and Treatment Response via Circulating Extracellular Vesicles. J Extracell Vesicles Gentile E, Corn PG, Zavridou M, Long JP, Song JH, Hoang A, Hahn AW, Dondossola E, Norton W, Lin SH, Logothetis CJ, Panaretakis T. PMID: 42844644 [PubMed - indexed for MEDLINE]
	A novel "early warning" system for biochemical recurrence in prostate cancer: development and validation of the SII-HALP combined score. BMC Cancer Wang Y, Fu G, Han D, Ye D. PMID: 42844604 [PubMed - indexed for MEDLINE]
	Critical appraisal of artificial intelligence studies for prostate cancer detection on MRI. Eur Radiol Pooch E, Agrotis G, Schoots IG, Emberton M, Kasivisvanathan V, Hu Y. PMID: 42844397 [PubMed - as supplied by publisher]
	Tislelizumab plus lenvatinib in advanced fumarate hydratase-deficient renal cell carcinoma: a single-arm, phase 2 trial with metabolic biomarker analysis. Nat Commun Kong W, Xu Y, Liu G, Lv W, Wang Z, Cao D, Jiao F, Hu J, Wu X, Huang J, Chen Y, Zhai W, Wu X, Pan J, Huang Y, Wu G, Zheng L, Xue W, Zhang J. PMID: 42844281 [PubMed - indexed for MEDLINE]
	Younger Age Is Associated With Slower PSA Decline After Low-Dose-Rate Brachytherapy for Localized Prostate Cancer. Int J Urol Nakai Y, Onishi K, Miyake M, Yamaki K, Isohashi F, Asakawa I, Tanaka N. PMID: 42844157 [PubMed - indexed for MEDLINE]
	Treatment-Effect Heterogeneity and a Simple Framework for Estimating Survival Benefit Associated With Local Therapy in Nonmetastatic Advanced Prostate Cancer: A Multicenter KAMU-ON Cohort Study. Int J Urol Iwamoto H, Izumi K, Machioka K, Toriumi R, Shima T, Nozaki M, Hori T, Inaba T, Nakagawa R, Kamijima T, Kadomoto S, Makino T, Naito R, Yaegashi H, Shigehara K, Nohara T, Miyagi T, Seto C, Kadono Y, Mizokami A. PMID: 42844150 [PubMed - indexed for MEDLINE]
	Re: Benedikt Hoeh, Giovanni Mazzucato, Pierre Tennstedt, et al. Natural History of Patients Eligible for PROTEUS Diagnosed with Prostate Cancer and Treated with Radical Prostatectomy Without Perioperative Systemic Treatment. Eur Urol Focus. In press. http://dx.doi.org/10.1016/j.euf.2026.05.002. Eur Urol Focus Rodriguez-Sanchez L, Giannarini G, Gomez-Rivas J, EAU Oncology Section Prostate Cancer Working Group. PMID: 42844119 [PubMed - as supplied by publisher]
	Oncological Outcomes of Neoadjuvant Chemotherapy in High-Risk UTUC: A Multicenter Study. Int J Urol Saito S, Sazuka T, Washino S, Kaneko G, Nagamoto S, Nakamura Y, Nakayama A, Pae S, Ando K, Yamada Y, Imamura Y, Sakamoto S. PMID: 42843987 [PubMed - indexed for MEDLINE]
	Clinical utility of combining the C-reactive protein-to-albumin ratio and systemic immune-inflammation index for prognostic assessment in metastatic renal cell carcinoma. PLoS One Muramoto N, Nagata M, Hirano H, Shirakawa T, China T, Kawano H, Isotani S, Ide H, Honda H, Horie S. PMID: 42842585 [PubMed - indexed for MEDLINE]
	Bridging the implementation gap in hereditary cancer care for prostate cancer: a narrative review and Japanese environmental scan. Int J Clin Oncol Habano E, Sato Y, Ogawa M, Watanabe K, Akiyama N, Chang H, Shijiki E, Nagai S, Kunita A, Ueki A, Kage H, Oda K. PMID: 42842178 [PubMed - as supplied by publisher]
	Kidney function changes following percutaneous cryoablation of renal tumors: A single-center cohort study. Adv Clin Exp Med Nowak , , Tomczak WA, Biesiadecki , Chorbi, Kruczek A, Gurwin A, Patrza, Karwacki J, Giudice FD, Chung BI, Ma, Szydelko T, Guzi, Krajewski W. PMID: 42841607 [PubMed - as supplied by publisher]
	Linear Accelerator-Based Stereotactic Body Radiotherapy of 36.25 Gy in Five Fractions for Localised Prostate Cancer: A Retrospective Single-Institution Cohort Study. J Med Imaging Radiat Oncol Katano A, Yamashita H. PMID: 42841368 [PubMed - as supplied by publisher]
	Isolated Prostatic Tuberculosis Coexisting with Benign Prostatic Hyperplasia: A Case Report. Int Med Case Rep J Modabber MH, Kamal MI, Sarwary MF, Bawarzai A, Sediqi M, Marofi M, Sadeqy L, Azizi A. PMID: 42841063 [PubMed - indexed for MEDLINE]
	Traditional Chinese medicine in non-muscle-invasive bladder cancer: a scoping review of syndrome characteristics and critical synthesis of pharmacological and mechanistic evidence. Front Pharmacol Zhang XZ, Xiang JA, Yang LC, Li YD, Zheng X, Qian J. PMID: 42840653 [PubMed]
	Impact of Cardio-cerebrovascular Diseases on Enzalutamide and Abiraterone Treatment in Castration-resistant Prostate Cancer. JMA J Kawai N, Izumi K, Yasui T, Shima T, Kato Y, Mita K, Okamura T, Inoue S, Tatarano S, Tanaka N, Kamiyama M, Chikazawa I, Hoshi S, Hashimoto K, Fukagai T, Shigehara K, Takahara S, Mizokami A. PMID: 42840419 [PubMed]
	Aromatic amine exposure and bladder cancer: a review of recent advances in epidemiology, pathogenesis, and prevention. Front Cell Dev Biol Li S, Zhang Y, Mao T, Wei J, Zhang W, Zhang J, Wei W. PMID: 42840084 [PubMed]
	Androgen receptor inhibitor double therapies in the management of metastatic castration-sensitive prostate cancer: a cost-effectiveness analysis. J Med Econ Padula WV, Cohen BG, Steel P, Appukkuttan S, Kalayeh B, Rettig M. PMID: 42839780 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 191880

Page 1 of 9594



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy